Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Ayton

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
The Medical Journal of Australia|February 10, 2022
Does the FDA-approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?Andrew Gleason, Scott Ayton, Ashley I Bush
Free Radical Biology & Medicine|November 13, 2012
Metallostasis in Alzheimer's diseaseScott Ayton, Peng Lei, Ashley I Bush
Frontiers in Aging Neuroscience|July 23, 2013
A delicate balance: Iron metabolism and diseases of the brainDominic Hare, Scott Ayton, Ashley Bush, et al.
Psychopharmacology|July 25, 2009
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophreniaWendy Adams, Scott Ayton, Maarten van den Buuse
Molecular Neurodegeneration|April 24, 2025
Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunitiesAbdel Ali Belaidi, Ashley I Bush, Scott Ayton
JAMA Neurology|November 29, 2016
Association of Cerebrospinal Fluid Ferritin Level With Preclinical Cognitive Decline in APOE-ε4 CarriersScott Ayton, Noel G Faux, Ashley I Bush
Nature Communications|May 20, 2015
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOEScott Ayton, Noel G Faux, Ashley I Bush, et al.
Cell Chemical Biology|October 21, 2017
Nanoscale Imaging Reveals Big Role for Iron in Alzheimer's DiseaseScott Ayton, Simon A James, Ashley I Bush
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Iron and Alzheimer's Disease: An Update on Emerging MechanismsDarius J R Lane, Scott Ayton, Ashley I Bush
Neurobiology of Disease|December 18, 2018
Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathologyIbrahima Diouf, Amir Fazlollahi, Ashley I Bush, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
The Medical Journal of Australia|February 10, 2022
Does the FDA-approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?Andrew Gleason, Scott Ayton, Ashley I Bush
Free Radical Biology & Medicine|November 13, 2012
Metallostasis in Alzheimer's diseaseScott Ayton, Peng Lei, Ashley I Bush
Frontiers in Aging Neuroscience|July 23, 2013
A delicate balance: Iron metabolism and diseases of the brainDominic Hare, Scott Ayton, Ashley Bush, et al.
Psychopharmacology|July 25, 2009
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophreniaWendy Adams, Scott Ayton, Maarten van den Buuse
Molecular Neurodegeneration|April 24, 2025
Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunitiesAbdel Ali Belaidi, Ashley I Bush, Scott Ayton
JAMA Neurology|November 29, 2016
Association of Cerebrospinal Fluid Ferritin Level With Preclinical Cognitive Decline in APOE-ε4 CarriersScott Ayton, Noel G Faux, Ashley I Bush
Nature Communications|May 20, 2015
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOEScott Ayton, Noel G Faux, Ashley I Bush, et al.
Cell Chemical Biology|October 21, 2017
Nanoscale Imaging Reveals Big Role for Iron in Alzheimer's DiseaseScott Ayton, Simon A James, Ashley I Bush
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Iron and Alzheimer's Disease: An Update on Emerging MechanismsDarius J R Lane, Scott Ayton, Ashley I Bush
Neurobiology of Disease|December 18, 2018
Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying β-amyloid pathologyIbrahima Diouf, Amir Fazlollahi, Ashley I Bush, et al.
Pageof 15